Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

Cited In for PubMed (Select 21727247)

1.

Psychoactive pharmaceuticals as environmental contaminants may disrupt highly inter-connected nodes in an Autism-associated protein-protein interaction network.

Kaushik G, Thomas MA, Aho KA.

BMC Bioinformatics. 2015;16 Suppl 7:S3. doi: 10.1186/1471-2105-16-S7-S3. Epub 2015 Apr 23.

2.

Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical Records.

Coleman KJ, Lutsky MA, Yau V, Qian Y, Pomichowski ME, Crawford PM, Lynch FL, Madden JM, Owen-Smith A, Pearson JA, Pearson KA, Rusinak D, Quinn VP, Croen LA.

J Autism Dev Disord. 2015 Jul;45(7):1989-96. doi: 10.1007/s10803-015-2358-0.

PMID:
25641003
3.

The effects of antenatal depression and antidepressant treatment on placental gene expression.

Olivier JD, Åkerud H, Skalkidou A, Kaihola H, Sundström-Poromaa I.

Front Cell Neurosci. 2015 Jan 13;8:465. doi: 10.3389/fncel.2014.00465. eCollection 2014.

4.

Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.

Glover ME, Pugh PC, Jackson NL, Cohen JL, Fant AD, Akil H, Clinton SM.

Neuroscience. 2015 Jan 22;284:775-97. doi: 10.1016/j.neuroscience.2014.10.044. Epub 2014 Nov 4.

PMID:
25451292
5.

Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort.

Brown AS, Surcel HM, Hinkka-Yli-Salomäki S, Cheslack-Postava K, Bao Y, Sourander A.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:86-92. doi: 10.1016/j.pnpbp.2014.10.010. Epub 2014 Oct 29.

PMID:
25445476
6.

Increased risk of autism spectrum disorders at short and long interpregnancy intervals in Finland.

Cheslack-Postava K, Suominen A, Jokiranta E, Lehti V, McKeague IW, Sourander A, Brown AS.

J Am Acad Child Adolesc Psychiatry. 2014 Oct;53(10):1074-81.e4. doi: 10.1016/j.jaac.2014.06.009. Epub 2014 Aug 1.

PMID:
25245351
7.

Spatial relative risk patterns of autism spectrum disorders in Utah.

Bakian AV, Bilder DA, Coon H, McMahon WM.

J Autism Dev Disord. 2015 Apr;45(4):988-1000. doi: 10.1007/s10803-014-2253-0.

PMID:
25241009
8.

Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Suri D, Teixeira CM, Cagliostro MK, Mahadevia D, Ansorge MS.

Neuropsychopharmacology. 2015 Jan;40(1):88-112. doi: 10.1038/npp.2014.231. Epub 2014 Sep 2.

PMID:
25178408
9.

Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.

Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, Erb JL, Churchill SE, Kaimal AJ, Doyle AE, Robinson EB, Smoller JW, Kohane IS, Perlis RH.

Mol Psychiatry. 2015 Jun;20(6):727-34. doi: 10.1038/mp.2014.90. Epub 2014 Aug 26.

PMID:
25155880
10.
11.

Gene × Environment interactions in autism spectrum disorders: role of epigenetic mechanisms.

Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G, Bonnot O, Weismann-Arcache C, Botbol M, Lauth B, Ginchat V, Roubertoux P, Barburoth M, Kovess V, Geoffray MM, Xavier J.

Front Psychiatry. 2014 Aug 4;5:53. doi: 10.3389/fpsyt.2014.00053. eCollection 2014. Review.

12.

Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.

Grzeskowiak LE, Gilbert AL, Morrison JL.

Ther Adv Drug Saf. 2013 Feb;4(1):27-37. doi: 10.1177/2042098612470389.

13.

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.

14.

Impairment of translation in neurons as a putative causative factor for autism.

Poliakov E, Koonin EV, Rogozin IB.

Biol Direct. 2014 Jul 10;9:16. doi: 10.1186/1745-6150-9-16.

15.
16.

Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Pediatrics. 2014 May;133(5):e1241-8. doi: 10.1542/peds.2013-3406. Epub 2014 Apr 14.

17.

Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.

Anderson G, Maes M.

Curr Neuropharmacol. 2014 Mar;12(2):148-67. doi: 10.2174/1570159X11666131120223757.

18.

Returning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges.

Osborne LM, Birndorf CA, Szkodny LE, Wisner KL.

Arch Womens Ment Health. 2014 Jun;17(3):239-46. doi: 10.1007/s00737-014-0421-z. Epub 2014 Mar 26.

19.

Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice.

Yu Q, Teixeira CM, Mahadevia D, Huang Y, Balsam D, Mann JJ, Gingrich JA, Ansorge MS.

Mol Psychiatry. 2014 Jun;19(6):688-98. doi: 10.1038/mp.2014.10. Epub 2014 Mar 4.

20.

Prenatal antidepressant exposure: clinical and preclinical findings.

Bourke CH, Stowe ZN, Owens MJ.

Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Print 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk